Claude Maraoui - 06 Mar 2025 Form 4 Insider Report for Journey Medical Corp (DERM)

Signature
/s/ Ramsey Alloush, attorney-in-fact
Issuer symbol
DERM
Transactions as of
06 Mar 2025
Net transactions value
-$203,451
Form type
4
Filing time
10 Mar 2025, 18:21:57 UTC
Previous filing
05 Mar 2025
Next filing
11 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DERM Common Stock, $0.0001 par value Sale $128,777 -25,551 -1.2% $5.04 2,067,323 06 Mar 2025 Direct F1, F2, F3
transaction DERM Common Stock, $0.0001 par value Sale $74,674 -14,905 -0.72% $5.01 2,052,418 07 Mar 2025 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the vesting of restricted stock units which vested as of various dates, a total of 25,551 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units.
F2 Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 6, 2025, was $5.00 to $5.26. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 Includes restricted stock units, which vest over various time periods.
F4 In connection with the vesting of restricted stock units which vested as of various dates, a total of 14,905 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units.
F5 Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 7, 2025, was $4.99 to $5.14. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.